These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia]. Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. Brandenburg JA; Marrie TJ; Coley CM; Singer DE; Obrosky DS; Kapoor WN; Fine MJ J Gen Intern Med; 2000 Sep; 15(9):638-46. PubMed ID: 11029678 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J J Infect; 2013 Jan; 66(1):34-40. PubMed ID: 22922634 [TBL] [Abstract][Full Text] [Related]
7. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. Li C; Gubbins PO; Chen GJ J Hosp Med; 2015 May; 10(5):287-93. PubMed ID: 25676363 [TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality among newly hospitalized patients with community-acquired pneumococcal bacteremia: a retrospective cohort study in three teaching hospitals in Japan. Suzuki H; Tokuda Y; Shichi D; Ishikawa H; Maeno T; Nakamura H Geriatr Gerontol Int; 2013 Jul; 13(3):607-15. PubMed ID: 22994197 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia]. Saldías P F; Viviani G P; Pulgar B D; Valenzuela F F; Paredes E S; Díaz P O Rev Med Chil; 2009 Dec; 137(12):1545-52. PubMed ID: 20361129 [TBL] [Abstract][Full Text] [Related]
10. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364 [TBL] [Abstract][Full Text] [Related]
11. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years. Jacups SP; Cheng A Vaccine; 2011 Jul; 29(33):5386-92. PubMed ID: 21651943 [TBL] [Abstract][Full Text] [Related]
12. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia. Arnold FW; Lopardo G; Wiemken TL; Kelley R; Peyrani P; Mattingly WA; Feldman C; Gnoni M; Maurici R; Ramirez JA; Respir Med; 2018 Jul; 140():115-121. PubMed ID: 29957272 [TBL] [Abstract][Full Text] [Related]
13. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438 [TBL] [Abstract][Full Text] [Related]
14. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia. Palma I; Mosquera R; Demier C; Vay CA; Famiglietti A; Luna CM J Bras Pneumol; 2012; 38(4):422-30. PubMed ID: 22964925 [TBL] [Abstract][Full Text] [Related]
15. Predictors and impact of time to clinical stability in community-acquired pneumococcal pneumonia. Takada K; Matsumoto S; Kojima E; Iwata S; Ninomiya K; Tanaka K; Goto D; Shimizu T; Nohara K Respir Med; 2014 May; 108(5):806-12. PubMed ID: 24589380 [TBL] [Abstract][Full Text] [Related]